Prime Medicine (PRME) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.41
-0.36
-0.3
-0.25

Details

Expected EPS
-0.250915
Actual EPS
-0.28
Surprise EPS
-0.03
Surprise Percent
+11.59%

Description

Prime Medicine (PRME) has reported earnings of -0.28 per share for Q2 2026.

0 Comments

Share your thoughts